Autoimmune liver disease-related autoantibodies in patients with biliary atresia

World J Gastroenterol. 2018 Jan 21;24(3):387-396. doi: 10.3748/wjg.v24.i3.387.

Abstract

Aim: To investigate the prevalence and clinical significance of autoimmune liver disease (ALD)-related autoantibodies in patients with biliary atresia (BA).

Methods: Sera of 124 BA patients and 140 age-matched non-BA controls were assayed for detection of the following autoantibodies: ALD profile and specific anti-nuclear antibodies (ANAs), by line-blot assay; ANA and anti-neutrophil cytoplasmic antibody (ANCA), by indirect immunofluorescence assay; specific ANCAs and anti-M2-3E, by enzyme linked immunosorbent assay. Associations of these autoantibodies with the clinical features of BA (i.e., cytomegalovirus infection, degree of liver fibrosis, and short-term prognosis of Kasai procedure) were evaluated by Spearman's correlation coefficient.

Results: The overall positive rate of serum autoantibodies in preoperative BA patients was 56.5%. ALD profile assay showed that the positive reaction to primary biliary cholangitis-related autoantibodies in BA patients was higher than that to autoimmune hepatitis-related autoantibodies. Among these autoantibodies, anti-BPO was detected more frequently in the BA patients than in the controls (14.8% vs 2.2%, P < 0.05). Accordingly, 32 (25.8%) of the 124 BA patients also showed a high positive reaction for anti-M2-3E. By comparison, the controls had a remarkably lower frequency of anti-M2-3E (P < 0.05), with 6/92 (8.6%) of patients with other liver diseases and 2/48 (4.2%) of healthy controls. The prevalence of ANA in BA patients was 11.3%, which was higher than that in disease controls (3.3%, P < 0.05), but the reactivity to specific ANAs was only 8.2%. The prevalence of ANCAs (ANCA or specific ANCAs) in BA patients was also remarkably higher than that in the healthy controls (37.9% vs 6.3%, P < 0.05), but showed no difference from that in patients with other cholestasis. ANCA positivity was closely associated with the occurrence of postoperative cholangitis (r = 0.61, P < 0.05), whereas none of the autoantibodies showed a correlation to cytomegalovirus infection or the stages of liver fibrosis.

Conclusion: High prevalence of autoantibodies in the BA developmental process strongly reveals the autoimmune-mediated pathogenesis. Serological ANCA positivity may be a useful predictive biomarker of postoperative cholangitis.

Keywords: Anti-neutrophilic cytoplasmic antibody; Anti-nuclear antibody; Autoantibodies; Autoimmune liver diseases; Biliary atresia.

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Antibodies, Antineutrophil Cytoplasmic / immunology
  • Antibodies, Antinuclear / blood*
  • Autoantigens / immunology
  • Biliary Atresia / blood*
  • Biliary Atresia / immunology
  • Biliary Atresia / surgery
  • Biomarkers / blood
  • Cholangitis, Sclerosing / blood*
  • Cholangitis, Sclerosing / immunology
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus Infections / blood
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / virology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Hepatitis, Autoimmune / blood*
  • Hepatitis, Autoimmune / immunology
  • Humans
  • Infant
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / immunology
  • Male
  • Portoenterostomy, Hepatic / adverse effects
  • Portoenterostomy, Hepatic / methods
  • Postoperative Complications / blood
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Preoperative Period
  • Prognosis
  • Retrospective Studies

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Antinuclear
  • Autoantigens
  • Biomarkers